Publication date: Aug 08, 2019
The primary goal of this work was to develop a computational tool to enable personalized prediction of pharmacological disposition and associated responses for opioids and antidotes. Here we present a computational framework for physiologically-based pharmacokinetic (PBPK) modeling of an opioid (morphine) and an antidote (naloxone). At present, the model is solely personalized according to an individual’s mass. These PK models are integrated with a minimal pharmacodynamic model of respiratory depression induction (associated with opioid administration) and reversal (associated with antidote administration). The model was developed and validated on human data for IV administration of morphine and naloxone. The model can be further extended to consider different routes of administration, as well as to study different combinations of opioid receptor agonists and antagonists. This work provides the framework for a tool that could be used in model-based management of pain, pharmacological treatment of opioid addiction, appropriate use of antidotes for opioid overdose and evaluation of abuse deterrent formulations.
German, C., Pilvankar, M., and Przekwas, A. Computational framework for predictive PBPK-PD-Tox simulations of opioids and antidotes. 03887. 2019 J Pharmacokinet Pharmacodyn.
- To End the Opioid Crisis, AACC Emphasizes That Clinical Laboratories, Healthcare Providers, and Federal Agencies Must Work Together
- 10 things you need to know about acute pain management
- To fight the opioid epidemic, we must first confront the nature of addiction
- Opioid-Induced Respiratory Depression Market Poised to Expand at a Robust Pace over 2019-2029
- Study Finds Increase in Pharmacy Dispensing of Naloxone, More Efforts Needed to Improve Access